Inhibition of the proteasomal function in chondrocytes down-regulates growth plate chondrogenesis and longitudinal

Shufang Wu1, Francesco De Luca

  • 1Section of Endocrinology and Diabetes, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania 19134, USA.

Endocrinology
|May 6, 2006
PubMed

Insights

Proteasome activity is crucial for growth plate chondrogenesis and longitudinal bone growth. Inhibiting the proteasome (PSI) suppressed chondrocyte proliferation and differentiation, hindering bone development.

Area of Science:

  • Cell Biology
  • Skeletal Biology
  • Biochemistry

Background:

  • The proteasome, a multiprotein complex, regulates intracellular proteins, including cell cycle regulators and transcription factors.
  • Proteasome activity, particularly its chymotrypsin-like component, influences osteoblast differentiation and bone formation.
  • The role of proteasomal activity within the growth plate remains largely unexplored.

Purpose of the Study:

  • To investigate the impact of proteasome inhibition on growth plate chondrocytes and longitudinal bone growth.
  • To elucidate the molecular mechanisms by which proteasomal activity affects chondrogenesis.

Main Methods:

  • Cultured rat metatarsal bones in the presence of proteasome inhibitor I (PSI).
  • Assessed chondrocyte proliferation, hypertrophy, differentiation, and apoptosis.
  • Analyzed the expression of beta-catenin and the DNA binding of nuclear factor kappaB (NF-κB) in cultured chondrocytes.

Main Results:

  • PSI significantly suppressed growth plate chondrocyte proliferation and hypertrophy/differentiation.
  • PSI induced chondrocyte apoptosis, leading to reduced metatarsal linear growth.
  • In chondrocytes, PSI increased beta-catenin expression and decreased NF-κB DNA binding.

Conclusions:

  • Proteasomal activity is essential for facilitating growth plate chondrogenesis.
  • Inhibition of proteasomal activity negatively impacts longitudinal bone growth by disrupting chondrogenesis.
  • These findings highlight the proteasome as a potential target for modulating bone growth.

Related Concept Videos

Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
8.2K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
4.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K